Skip to main content
Practice Management
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Practice Management
Resource Center
News
News
Resources
FDA Alerts
Pearls of Wisdom
From the Journal
Insights
Commentary
Podcasts
Videos
Interactive
Polls
Quizzes
FDA Alerts
Practice Management
Practice Management
FDA Roundup: Powdered Gloves, Opioid Warnings, Anthrax
03/22/2016
The FDA has proposed a ban on powdered medical gloves, approved new requirements for opioid warning labels, and approved a new treatment for inhalational anthrax.
03/22/2016
FDA
FDA
The FDA and Doctors: Why We Need to Pay Attention
03/23/2015
William H. Eaglstein, MD
William H. Eaglstein, MD
I am often surprised that any doctors and medical students miss the mark on what FDA stands for.
03/23/2015